Anebulo Pharmaceuticals, Inc. (ANEB)
OTCMKTS · Delayed Price · Currency is USD
1.020
+0.106 (11.60%)
Mar 23, 2026, 3:38 PM EST
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $42.01 million as of March 24, 2026. Its market cap has decreased by -4.44% in one year.
Market Cap
42.01M
Enterprise Value
32.97M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.02
Market Cap Chart
Since May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from 165.19M to 42.01M, a decrease of -74.57%. That is a compound annual growth rate of -24.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 41.60M | 0.25% |
| Dec 31, 2025 | 41.50M | -4.76% |
| Dec 31, 2024 | 43.57M | -29.77% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -13.09% |
| May 7, 2021 | 165.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HST Global | 88.40M |
| Nuo Therapeutics | 60.36M |
| Vicapsys Life Sciences | 48.56M |
| Cell Source | 37.29M |
| ZIVO Bioscience | 33.01M |
| Harvard Apparatus Regenerative Technology | 29.49M |
| Arch Biopartners | 27.04M |
| Provectus Biopharmaceuticals | 21.22M |